Catalyst Funds Management’s Acrivon Therapeutics ACRV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,044
Closed -$7.47K 1148
2024
Q1
$7.47K Buy
+1,044
New +$7.47K ﹤0.01% 929